首页> 外文期刊>International journal of molecular medicine >Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study
【24h】

Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study

机译:具有高密度儿茶素的绿茶改善了肝功能和脂肪浸润在非酒精脂肪肝病(NAFLD)患者中:双盲安慰剂对照研究

获取原文
           

摘要

Catechins, a major component of green tea extract, have anti-hyperlipidemic effects. The present study investigated the effects of consumption of green tea with high-density catechins in non-alcoholic fatty liver disease (NAFLD) patients. Seventeen patients with NAFLD consumed green tea with high-density catechins, low-density catechins or a placebo for 12 weeks in a randomized double-blind study. Ultrasonography and computed tomography (CT) were performed at baseline and after 12 weeks. Serum alanine aminotransferase (ALT) levels and urine 8-isoprostane were monitored and compared to baseline at 4, 8 and 12 weeks. Body fat was significantly decreased in the high-density catechin group compared with the placebo and low-density catechin groups after 12 weeks of consumption. All the patients in the high-density catechin group showed a significantly improved liver-to-spleen CT attenuation ratio compared with the placebo and low-density catechin groups after 12 weeks of consumption. The high-density catechin group significantly decreased serum ALT levels and reduced urinary 8-isoprostane excretion compared with the placebo and low-density catechin group after 12 weeks of consumption. Based on a reduced proportion of body fat as estimated by bioimpedance measurement, increased liver-to-spleen CT attenuation ratio, decreased serum ALT levels and reduced urinary 8-isoprostane excretion, we concluded that 12?weeks of 700?ml per day of green tea containing >1?g catechin improved liver fat content and inflammation by reducing oxidative stress in patients with NAFLD.
机译:儿茶素是绿茶提取物的主要成分,具有抗高脂血症的影响。本研究研究了绿茶消费与高密度儿茶素在非酒精脂肪肝病(NAFLD)患者中的影响。 17例NAFLD患者用高密度儿茶素,低密度儿茶素或安慰剂在随机的双盲研究中消耗了绿茶。超声检查和计算断层扫描(CT)在基线和12周后进行。监测血清丙氨酸氨基转移酶(ALT)水平和尿8-异前烷,并与4,8和12周的基线进行比较。在消耗12周后,高密度儿茶素组中,体脂在高密度儿茶素组中显着降低。在消耗12周后,高密度儿茶素组中的所有患者都显示出显着改善的肝 - 脾脏CT衰减比,与安慰剂和低密度儿茶素组相比。高密度的儿茶素组在消耗12周后,与安慰剂和低密度儿茶素组相比,血清ALT水平显着降低,降低了尿8-异前列烷排泄。基于由生物阻抗测量估计的体脂比例减少,增加了肝转脾衰减率,降低了血清ALT水平,降低了尿8-异前烷排泄,我们得出结论,每天为每天绿色700?ml含有> 1?G儿茶素通过降低NAFLD患者的氧化胁迫改善肝脂肪含量和炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号